Century Therapeutics, Inc.
IPSC
$1.92
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.55M | -21.65M | -19.17M | -34.43M | -32.54M |
| Total Depreciation and Amortization | 2.62M | 3.00M | 3.55M | 3.13M | 3.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.41M | -172.00K | -3.61M | 6.51M | 2.45M |
| Change in Net Operating Assets | 687.00K | -6.45M | 3.16M | -795.00K | -704.00K |
| Cash from Operations | -19.83M | -25.26M | -16.08M | -25.58M | -27.59M |
| Capital Expenditure | -694.00K | -584.00K | 139.00K | -195.00K | -317.00K |
| Sale of Property, Plant, and Equipment | 59.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 18.40M | -112.03M | 22.22M | 24.87M | 32.86M |
| Cash from Investing | 17.77M | -112.62M | 22.36M | 24.67M | 32.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 311.00K | 126.62M | 53.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 311.00K | 126.62M | 53.00K | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.76M | -11.25M | 6.34M | -913.00K | 4.95M |